HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Pinton Selected Research

Carcinoma (Carcinomatosis)

1/2021Concise synthesis and biological evaluation of 2-Aryl-3-Anilinobenzo[b]thiophene derivatives as potent apoptosis-inducing agents.
1/2014Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Pinton Research Topics

Disease

68Neoplasms (Cancer)
04/2024 - 06/2008
22Inflammation (Inflammations)
11/2023 - 04/2011
13Mitochondrial Diseases (Mitochondrial Disease)
04/2024 - 06/2010
11Carcinogenesis
01/2023 - 10/2010
10Cystic Fibrosis (Mucoviscidosis)
10/2023 - 04/2011
7Reperfusion Injury
11/2023 - 01/2015
7Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 09/2002
7Hypoxia (Hypoxemia)
07/2023 - 06/2008
5Wolfram Syndrome (Syndrome, Wolfram)
04/2024 - 10/2018
5Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 01/2013
5Autosomal Dominant Polycystic Kidney (ADPKD)
01/2023 - 04/2005
5Disease Progression
03/2022 - 01/2011
5ST Elevation Myocardial Infarction
01/2021 - 10/2016
4Neoplasm Metastasis (Metastasis)
01/2023 - 01/2015
4Multiple Sclerosis
01/2021 - 01/2017
4Down Syndrome (Down's Syndrome)
01/2020 - 08/2014
3Ischemia
11/2023 - 01/2015
3Prostatic Neoplasms (Prostate Cancer)
07/2022 - 01/2016
3Myocardial Infarction
01/2022 - 10/2016
3Heart Failure
01/2022 - 10/2017
3Mesothelioma
11/2021 - 01/2017
3Lung Diseases (Lung Disease)
01/2021 - 11/2016
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 04/2015
3Cognitive Dysfunction
12/2019 - 07/2014
2Psoriatic Arthritis
12/2023 - 03/2023
2Pneumonia (Pneumonitis)
11/2023 - 01/2020
2Seizures (Absence Seizure)
10/2023 - 01/2017
2Inborn Genetic Diseases (Disease, Hereditary)
01/2023 - 01/2020
2Heart Diseases (Heart Disease)
01/2022 - 01/2015
2Genomic Instability
04/2021 - 05/2015
2Carcinoma (Carcinomatosis)
01/2021 - 01/2014
2Atherosclerosis
01/2021 - 10/2019
2Malignant Mesothelioma
01/2020 - 09/2015
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 11/2019
2Pseudomonas Infections
01/2020 - 10/2018
2Bacterial Infections (Bacterial Infection)
01/2020 - 04/2011
2Central Nervous System Cavernous Hemangioma
10/2019 - 01/2016
2Global Cerebral Hypomyelination
09/2019 - 01/2017
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 01/2016
2Muscular Diseases (Myopathy)
01/2019 - 04/2015
2Parkinson Disease (Parkinson's Disease)
12/2018 - 01/2017
2Colonic Neoplasms (Colon Cancer)
01/2018 - 12/2014
2Weight Gain
06/2017 - 04/2011
2Benign Familial Pemphigus (Hailey Hailey Disease)
03/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
10/2023 - 09/2002
21CalciumIBA
04/2024 - 06/2009
13Adenosine Triphosphate (ATP)IBA
02/2023 - 07/2003
12Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 04/2005
8Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2014
6InflammasomesIBA
10/2023 - 01/2016
5mitochondrial calcium uniporterIBA
04/2024 - 01/2013
5Protein Isoforms (Isoforms)IBA
05/2021 - 04/2005
5MicroRNAs (MicroRNA)IBA
01/2021 - 01/2013
5Phosphotransferases (Kinase)IBA
01/2018 - 09/2013
4Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2023 - 01/2020
4Mitochondrial DNA (mtDNA)IBA
01/2022 - 06/2010
4Metformin (Glucophage)FDA LinkGeneric
01/2020 - 04/2005
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2018 - 01/2014
3Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
04/2024 - 05/2015
3Oxygen (Dioxygen)IBA
07/2023 - 01/2014
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2023 - 06/2008
3AsbestosIBA
11/2021 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
04/2021 - 01/2014
3Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 04/2011
3LipidsIBA
10/2020 - 07/2017
3AntioxidantsIBA
01/2019 - 04/2005
3Mitochondrial Permeability Transition PoreIBA
01/2019 - 01/2014
3Interleukin-8 (Interleukin 8)IBA
10/2018 - 04/2011
3Protein Kinase CIBA
06/2017 - 04/2005
3ChemokinesIBA
01/2017 - 11/2016
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2017 - 04/2014
2LigandsIBA
11/2023 - 01/2022
2Interleukin-6 (Interleukin 6)IBA
11/2023 - 10/2023
2ElementsIBA
02/2023 - 01/2015
2Molecular Chaperones (Chaperone, Molecular)IBA
01/2023 - 01/2023
2Purinergic P2X7 ReceptorsIBA
01/2023 - 01/2016
2MTOR InhibitorsIBA
01/2023 - 01/2018
2ChloridesIBA
01/2023 - 01/2022
2CytokinesIBA
01/2023 - 01/2017
2EnzymesIBA
12/2022 - 01/2018
2Calcium Channels (Calcium Channel)IBA
01/2022 - 11/2016
2HMGB1 Protein (HMG1)IBA
11/2021 - 10/2020
2Caspase 3 (Caspase-3)IBA
01/2021 - 01/2014
2Heme (Haem)IBA
01/2021 - 12/2012
2Lactic Acid (Lactate)FDA LinkGeneric
10/2020 - 01/2011
2Pioglitazone (Actos)FDA Link
01/2020 - 01/2019
2Retinaldehyde (Retinal)IBA
01/2020 - 07/2015
2N-acetylaspartate (N-acetyl aspartate)IBA
09/2019 - 01/2017
2Aspartic Acid (Aspartate)FDA Link
09/2019 - 01/2017
2Phospholipases (Phospholipase)IBA
10/2018 - 04/2011
2Protease La (Endopeptidase La)IBA
01/2018 - 12/2014
2Sirolimus (Rapamycin)FDA Link
04/2017 - 06/2008
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2017 - 04/2014
2Magnesium ChlorideFDA LinkGeneric
03/2016 - 01/2015
2Transcription Factors (Transcription Factor)IBA
01/2016 - 04/2015

Therapy/Procedure

33Therapeutics
03/2024 - 06/2010
4Percutaneous Coronary Intervention
10/2017 - 10/2016
2Radiotherapy
06/2021 - 05/2021
2Drug Therapy (Chemotherapy)
01/2021 - 01/2018
2Patient Readmission
10/2017 - 10/2017